Related Experiment Video
Updated: Sep 26, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Spiramycin versus penicillin V in the empiric treatment of bacterial tonsillitis
Abstract:
The efficacy and safety of spiramycin were compared with those of penicillin V in the treatment of 55 patients with acute bacterial tonsillitis. The most frequently isolated pathogens were streptococci and about one-third were group A/beta haemolytic streptococci. There was one clinical failure in the patients treated with penicillin, and none with spiramycin. No side effects were reported in either of the treatment groups. Thus in this study, spiramycin proved to be equivalent to penicillin in the treatment of acute bacterial tonsillitis in adults.
Insights
Spiramycin demonstrated equal effectiveness and safety to penicillin V for treating acute bacterial tonsillitis in adults. This study found no side effects in either treatment group, suggesting spiramycin as a viable alternative.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Acute bacterial tonsillitis is a common infection, frequently caused by streptococci.
- Penicillin V has been a standard treatment, but alternatives are sought for efficacy and safety.
- Understanding pathogen prevalence, including Group A beta-hemolytic streptococci, is crucial for effective treatment.
Purpose of the Study:
- To compare the efficacy and safety of spiramycin versus penicillin V in treating acute bacterial tonsillitis.
- To evaluate clinical outcomes and side effects associated with each antibiotic.
- To determine if spiramycin is a suitable alternative to penicillin V for this condition.
Main Methods:
- A comparative study involving 55 adult patients diagnosed with acute bacterial tonsillitis.
- Patients were randomized to receive either spiramycin or penicillin V.
- Pathogen identification, primarily focusing on streptococci, was performed.
Main Results:
- The most common pathogens identified were streptococci, with approximately one-third being Group A beta-hemolytic streptococci.
- One clinical failure occurred in the penicillin V group; no failures were reported in the spiramycin group.
- No adverse side effects were observed in patients receiving either spiramycin or penicillin V.
Conclusions:
- Spiramycin showed equivalent clinical efficacy to penicillin V in treating acute bacterial tonsillitis in adults.
- Both treatments were well-tolerated, with no reported side effects.
- Spiramycin represents a safe and effective alternative antibiotic option for acute bacterial tonsillitis.
More Related Videos
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Production of Antibiotics
Inhibitors of Gram-positive Cell Wall Synthesis